Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
OCULAR THERAPEUTIX, INC (OCUL) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 8-K Investor presentation
Docs: "Ocular Therapeutix, Inc. slide presentation"
10/03/2023 8-K Other Events  Interactive Data
08/07/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/07/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/07/2023 8-K Quarterly results
Docs: "Ocular Therapeutix™ Provides Second Quarter 2023 Financial Results and Corporate Update"
07/12/2023 8-K Quarterly results
07/07/2023 8-K Entry into a Material Definitive Agreement  Interactive Data
Docs: "Agreements"
06/16/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/12/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "0 4 8 12 16 20 24 28 32 36 40 44 48 52"
05/08/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/08/2023 8-K Quarterly results
Docs: "EXHIBI 99.1"
05/01/2023 ARS Form ARS - Annual Report to Security Holders:
05/01/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/01/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/06/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
03/06/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/06/2023 10-K Annual Report for the period ended December 31, 2022
03/06/2023 8-K Quarterly results
Docs: "Ocular Therapeutix™ Provides Fourth Quarter and Year-End 2022 Results and Corporate Update"
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 5.2% stake in Ocular Therapeutix Inc.
01/06/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Ocular Therapeutix™ Provides 2022 Year End Corporate Update and Reviews Expected 2023 Milestones"
11/07/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/07/2022 8-K Quarterly results
Docs: "Ocular Therapeutix™ Reports Third Quarter 2022 Financial Results and Business Update"
09/29/2022 8-K Quarterly results
08/08/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/08/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/08/2022 8-K Quarterly results
06/17/2022 8-K Quarterly results
06/08/2022 8-K Quarterly results
05/11/2022 EFFECT Form EFFECT - Notice of Effectiveness:
05/09/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/09/2022 8-K Quarterly results
Docs: "Ocular Therapeutix™ Reports First Quarter 2022 Financial Results and Business Update"
05/02/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/02/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy